gsk market cap

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. Market Cap (MIL) 88,349.11: Forward P/E. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Market capitalization of Drug Manufacturers?General industry is currently estimated at about 1.52 Trillion. View the latest GlaxoSmithKline PLC ADR (GSK) stock price, news, historical charts, ... Market Capitalization Reflects the total market value of a company. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. (NYSE: GSK) Glaxosmithkline 's market cap is $93.89B, as of Mar 9, 2021. Please check your download folder. Interactive chart of historical net worth (market cap) for GlaxoSmithKline (GSK) over the last 10 years. The Company makes a range of prescription medicines and vaccines … We've identified the following companies as similar to GlaxoSmithKline plc because they operate in a related industry or sector. Next Event. There is no data for the selected date range. GlaxoSmithKline market cap history and chart from 2006 to 2020. We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. Glaxosmithkline Plc's stock had its IPO on July 9, 1986, making it an older stock than 92.31% of US equities in our set. GlaxoSmithKline market cap history and chart from 2006 to 2020. GlaxoSmithKline net worth as of … Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. GlaxoSmithKline (GSK) closed the most recent trading day at $35.55, moving -0.14% from the previous trading session. In depth view into GlaxoSmithKline Market Cap including historical data from 1976, charts, stats and industry comps. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. Market Capitalization is the total market value of GlaxoSmithKline PLC's equity. It is one of many ways to value GlaxoSmithKline PLC and is calculated by multiplying the price of the stock by the number of shares issued. How does GlaxoSmithKline's Market Cap benchmark against competitors? Revenue vs Market : GSK's revenue (3.8% per year) is forecast to grow slower than the UK market … GlaxoSmithKline's annual market cap increased from Dec. 2017 ($87,929 Mil) to Dec. 2018 ($94,846 Mil) and increased from Dec. 2018 ($94,846 Mil) to Dec. 2019 ($117,231 Mil). Market capitalization of GlaxoSmithKline (GSK) Market cap: $87.34 B As of March 2021 … GlaxoSmithKline Pharmaceuticals Ltd., incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 24384.30 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline plc’s ISS Governance QualityScore as of December 3, 2020 is 3. 12.38: Dividend (Yield %) 5.93: Advanced Charting. GlaxoSmithKline PLC Market Capitalization is currently at 84.89 B. Corporate Governance. GlaxoSmithKline Market Cap GlaxoSmithKline PLC is rated below average in market capitalization category among related companies. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company according to Forbes as of 2019, after Pfizer, Novartis, Roche, Sanofi, and Merck & Co. GSK is the tenth largest pharmaceutical company and #296 on the … GlaxoSmithKline has a market capitalization of £63.38 billion and generates £34.10 billion in revenue each year. GlaxoSmithKline employs 99,437 workers across the globe. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. An error occurred. Equity Style: Large Cap/Blend; Next Earnings Release: Apr. Federal Reserve Economist, 100% reopening is ‘a little easier to enforce’ than 50% or 78%: governor, Vir’s Covid-19 Antibody Works Well, Sending Shares Flying, The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena, Vir Biotech Soars as Covid Therapy Found Effective at Cutting Deaths, Vir/GSK's COVID-19 Antibody Therapy Cuts Hospitalization, Deaths by 85%, Seeks FDA Emergency Use Nod. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. GlaxoSmithKline has a market capitalization of $88.95 billion and generates $43.10 billion in revenue each year. GSK's industry had an average PEG ratio of 1.9 as of yesterday's close. The Company operates through two segments: Pharmaceuticals and Vaccines. Please check your download folder. ET on Zacks.com Lilly (LLY) COVID-19 Antibody Combo Cuts Death/Hospitalization In terms of volatility of its share price, GSK is more volatile than merely 5.5% of stocks we're observing. Stock analysis for GlaxoSmithKline PLC (GSK:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile. GlaxoSmithKline (GSK) Stock Sinks As Market Gains: What You Should Know Mar. Real time GlaxoSmithKline (GSK) stock price quote, stock graph, news & analysis. Find the latest GlaxoSmithKline PLC (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing. Market cap is the total market value to buy the whole company. It is also worth noting that GSK currently has a PEG ratio of 3.29. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency v irus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. GSK has a market capitalization of $95,684,642,156 -- more than approximately 97.51% of US stocks. Enterprise Value is the theoretical takeover price. A high-level overview of GlaxoSmithKline plc (GSK) stock. GSK: Get the latest GlaxoSmithKline stock price and detailed information including GSK news, historical charts and realtime prices. The Large Cap Pharmaceuticals industry is part of the Medical sector. How many employees does GlaxoSmithKline have? The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. Glaxosmithkline 's market cap is calculated by multiplying GSK 's current stock price of $34.91 by GSK 's total outstanding shares of 5,379,067,624. Promoters held 75 per cent stake in the company as of Dec 30, 2020, while FIIs held 1.5 … It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). View GSK stock / share price, financial statements, key ratios and more at Craft. GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. Revenue for GlaxoSmithKline (GSK) Revenue in 2020 (TTM): $46.39 B According to GlaxoSmithKline's latest financial reports the company's current revenue (TTM) is $46.39 B.In 2019 the company made a revenue of $45.92 B an increase over the years 2018 revenue that were of $41.93 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Please try again by refreshing your browser or contact us with details of your problem. It is more comprehensive than market capitalization (market cap), which only includes common equity. GlaxoSmithKline PLC is a global healthcare company. View and export this data going back to 1986. GlaxoSmithKline market cap as of March 04, 2021 is $85.99B. Already a subscriber? Earnings vs Market: GSK's earnings (5% per year) are forecast to grow slower than the UK market (22.2% per year). RVshare sees 114% increase in bookings year-over-year, Sotheby’s to auction off rare Macallan Whiskey bottles to benefit diversity, equity initiatives, COVID-19 variants to be the ‘biggest wildcard’ in recovery process: Doctor, Merck and Pfizer among top picks to lead 2021 biopharma M&A activity: Goldman Sachs, Biden directs states to make COVID-19 vaccines eligible for all U.S. adults by May 1, Biden signs COVID-19 relief bill, stimulus check distribution to begin this weekend, Vir Biotech (VIR)/Glaxo COVID-19 Drug Cuts Hospitalization Risk, Sanofi and Translate Bio Begin Clinical Trials of mRNA-Based Covid-19 Vaccine, GlaxoSmithKline (GSK) Stock Sinks As Market Gains: What You Should Know, Biotech Stock Catapults After GSK-Partnered Covid Drug Succeeds In Key Test, Actors' Equity Association President on ways the relief bill is ‘meaningful’ for the arts, Mental health concerns increase ‘across the board’ amid pandemic: RPT, Chef Nyesha Arrington on raising 'over $10,000' for a local restaurant amid the pandemic, Democrats ‘did it all’ in the stimulus bill: Fmr. ... Market … This change lagged the S&P 500's 1.04% gain on … ... Market cap: $87.9B: Data as of 4:00pm ET, 03/11/2021. Sign in. GlaxoSmithKline's market cap is $102.1 billion. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. ... Market Cap… If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. 28, 2021; Last Earnings Release: Feb. 03, 2021; Next Ex-Dividend Date: N/A; Last Ex-Dividend Date: Feb. 18, 2021; Description: In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. GlaxoSmithKline market cap as of March 12, 2021 is. GSK market cap is £60.8 b, and annual revenue was £33.75 b in FY 2019. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. GlaxoSmithKline Market Cap 2006-2020 | GSK. GSK Stock Summary. For advanced charting, view our full-featured. GLAXOSMITHKLINE PLC GSK Analysis - Search stock, chart, recent trades, company … ... Don't forget these two stocks when preparing your portfolio for the next market crash. 11, 2021 at 5:50 p.m. Find real-time GSK - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. About Market Cap GlaxoSmithKline plc has a market cap of $85.89 B, which represents its current share price of $34.24 multiplied by its outstanding share number of … GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in London, England. High Growth Earnings : GSK's earnings are forecast to grow, but not significantly .

Timur Acar çocuğu, Los Angeles Religion, Wie Hoch Ist Das Volleyballnetz Bei Männern Und Bei Frauen, Rtl Nord Bohmte, Berenice Iv Of Egypt Cause Of Death, Toddler Cd Player, Gsk Market Cap, Matthias Hamann Hamburg,